Home
Conditions
Cecal Neoplasms

Clinical trial condition

Cecal Neoplasms

Explore clinical trials studying Cecal Neoplasms. Study availability and eligibility vary by location and protocol.

68 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Cecal Neoplasms trial results

Completed

Severe Neutropenia After HIPEC Using Mitomycin-C

NCT05513183

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Neoplasm, +18 more
Locations: Division of Colon and Rectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea Seoul, South Korea

View Trial Details

Completed

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

NCT02963831

Conditions: Adnexal Diseases, Appendiceal Cancer, Appendiceal Neoplasms, +27 more
Locations: Research Facility San Diego, California, United States

Research Facility Miami, Florida, United States

Research Facility Buffalo, New York, United States

Research Facility New York, United States

View Trial Details

Completed

Programs To Support You During Chemotherapy

NCT02489422

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +55 more
Locations: Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

NCT03604653

Conditions: Adnexal Diseases, Appendiceal Cancer, Appendiceal Neoplasms, +40 more
Locations: Holy Name Medical Center Teaneck, New Jersey, United States

View Trial Details

Completed

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma

NCT05452382

Conditions: Appendiceal Cancer, Appendiceal Neoplasms, Cecal Diseases, +9 more
Locations: Cleveland Clinic Flroida Weston, Florida, United States

View Trial Details

Completed

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

NCT02833753

Conditions: Abdominal Neoplasms, Appendiceal Neoplasms, Appendix Cancer, +17 more
Locations: UMass Memorial Medical Center - University Campus Worcester, Massachusetts, United States

View Trial Details

Completed

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

NCT00016380

Conditions: Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +55 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada

Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada

British Columbia Cancer Agency Vancouver, British Columbia, Canada

View all 14 locations

View Trial Details

Completed

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

NCT00003867

Conditions: Adenocarcinoma, Anus Diseases, Anus Neoplasms, +47 more
Locations: Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States

View Trial Details

Completed

Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer

NCT00310076

Conditions: Appendiceal Neoplasms, Carcinoma of the Appendix, Cecal Diseases, +15 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer

NCT00458809

Conditions: Appendiceal Neoplasms, Carcinoma of the Appendix, Cecal Diseases, +16 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Cecal Neoplasms

Cecal Neoplasms trial results

Related conditions